4
Changes in Ownership
Lyell Immunopharma, Inc. Filed Acc 0001209191-23-048779
Options or other derivatives
- Director acquired 55,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Bishop Hans Edgar · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-09-08 | Grant or award : show line 1 in the form Option (right to buy) | +55,000 | $3.19 | 2033-09-07 | 55,000 | 55,000 | D |
Loading xslF345X05/doc4.xml…